Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR
Following an announcement by the Indian Council of Medical Research (ICMR) and Panacea Biotec Limited to initiate third phase trials, about 8,000 of the targeted 10,000 participants have enrolled in…







